• Alnylam Pharmaceuticals will release results for the quarter ending Sept. 30, 2026, on Oct. 29, 2026, before U.S. markets open.
• Management will discuss results, company developments and future expectations during a conference call on Oct. 29, 2026, at 8:30 a.m. ET.
• A live webcast will accompany the call; a replay will be available approximately two hours later on Oct. 29, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610150800BIZWIRE_USPR_____20261015_BW375573) on October 15, 2026, and is solely responsible for the information contained therein.